Digital Content 
NEWS #PharmaBuzz
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alar-pharmaceuticals-announces-first-patient-dosing-in-a-study-of-ala-3000-extended-release-ketamine-injection-for-treatment-resistant-depression-trd-302454659.html
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3071310/0/en/Silo-Pharma-s-SP-26-Ketamine-Implant-Meets-All-Endpoints-in-Fibromyalgia-Study.html
16 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/mira-pharmaceuticals-announces-positive-results-for-ketamir-2-in-diab-1015232
03 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tasman-therapeutics-advancing-oral-ketamine-program-to-pivotal-phase-3-studies-302419722.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040486/0/en/PharmaTher-Receives-US-FDA-Approval-Goal-Date-for-Ketamine.html
12 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/12/3024966/0/en/PharmaTher-Provides-Update-on-FDA-New-Drug-Application-for-Ketamine.html
Share 